All Stories

  1. 6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL INCONTINENCE

    Article • Neurourology and Urodynamics, August 2018, Wiley

    Professor Katl-Erik Andersson, Dr Peter F.W.M. Rosier

  2. The serotonin (5-hydroxytryptamine) 5-HT7 receptor is up-regulated in Onuf's nucleus in rats with chronic spinal cord injury

    Article • BJU International, June 2018, Wiley

    Professor Katl-Erik Andersson

  3. Chronic spinal cord injury causes upregulation of serotonin (5-HT)2A and 5-HT2C receptors in lumbosacral cord motoneurons

    Article • BJU International, August 2017, Wiley

    Professor Katl-Erik Andersson

  4. Mechanisms of ATP release - future therapeutic targets?

    Article • BJU International, May 2015, Wiley

    Professor Katl-Erik Andersson

  5. Chronic Pelvic Ischemia: Contribution to the Pathogenesis of Lower Urinary Tract Symptoms (LUTS): A New Target for Pharmacological Treatment?

    Article • LUTS Lower Urinary Tract Symptoms, November 2014, Wiley

    Professor Katl-Erik Andersson

  6. New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA

    Article • Therapeutics and Clinical Risk Management, April 2013, Taylor & Francis

    Professor Katl-Erik Andersson

  7. Inhibition of adrenergic human prostate smooth muscle contraction by the inhibitors of c-Jun N-terminal kinase, SP600125 and BI-78D3

    Article • British Journal of Pharmacology, June 2012, Wiley

    Professor Katl-Erik Andersson

  8. PUK3 ASSESSMENT OF COMORBIDITIES IN PATIENTS WITH OVERACTIVE BLADDER (OAB) DISORDER: AN ELECTRONIC MEDICAL RECORD (EMR) DATA ANALYSIS

    Article • Value in Health, November 2010, Elsevier

    Professor Katl-Erik Andersson

  9. Overactive bladder

    Article • July 2007, Taylor & Francis

    Professor Katl-Erik Andersson

  10. Antimuscarinics for treatment of overactive bladder

    Article • The Lancet Neurology, January 2004, Elsevier

    Professor Katl-Erik Andersson